Cover Story
For a decade, thousands of PhDs in epigenetics may have been relying on the wrong tool as they study the biological processes that regulate how and when genes are expressed or silenced.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump
- Canine cancers as models: We have barely tapped the full potential of comparative oncology
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Cold Spring Harbor and Northwell extend collaboration with $150M commitment
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community